Your browser doesn't support javascript.
loading
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.
Burns, Daniel; Anokian, Ezequiel; Saunders, Edward J; Bristow, Robert G; Fraser, Michael; Reimand, Jüri; Schlomm, Thorsten; Sauter, Guido; Brors, Benedikt; Korbel, Jan; Weischenfeldt, Joachim; Waszak, Sebastian M; Corcoran, Niall M; Jung, Chol-Hee; Pope, Bernard J; Hovens, Chris M; Cancel-Tassin, Géraldine; Cussenot, Olivier; Loda, Massimo; Sander, Chris; Hayes, Vanessa M; Dalsgaard Sorensen, Karina; Lu, Yong-Jie; Hamdy, Freddie C; Foster, Christopher S; Gnanapragasam, Vincent; Butler, Adam; Lynch, Andy G; Massie, Charlie E; Woodcock, Dan J; Cooper, Colin S; Wedge, David C; Brewer, Daniel S; Kote-Jarai, Zsofia; Eeles, Rosalind A.
Afiliación
  • Burns D; The Institute of Cancer Research, London, UK.
  • Anokian E; The Institute of Cancer Research, London, UK.
  • Saunders EJ; The Institute of Cancer Research, London, UK.
  • Bristow RG; Manchester Cancer Research Centre and CRUK Manchester Institute, The University of Manchester, Manchester, UK.
  • Fraser M; Princess Margaret Cancer Centre/University Health Network, Toronto, Ontario, Canada; Computational Biology Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Reimand J; Computational Biology Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Department of Medical Biophysics & Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Schlomm T; Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Sauter G; University Medical Centre Hamburg - Eppendorf, Hamburg, Germany.
  • Brors B; German Cancer Research Center (DKFZ), Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Korbel J; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
  • Weischenfeldt J; Charité - Universitätsmedizin Berlin, Berlin, Germany; Biotech Research & Innovation Centre (BRIC) & Finsen Laboratory, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
  • Waszak SM; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA; Department of Pediatric Research, Division of Pediatric and Adolescent Medici
  • Corcoran NM; Department of Surgery, The University of Melbourne, Grattan Street, Parkville, Victoria, Australia; Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia; Melbourne Bioinformatics, The University of Melbourne, Grattan Street, Victoria, Australia.
  • Jung CH; The University of Melbourne, Grattan Street, Parkville, Victoria, Australia.
  • Pope BJ; Department of Surgery, The University of Melbourne, Grattan Street, Parkville, Victoria, Australia; Royal Melbourne Hospital, Melbourne, Parwille, Victoria, Australia.
  • Hovens CM; Melbourne Bioinformatics, The University of Melbourne, Grattan Street, Victoria, Australia; The University of Melbourne, Grattan Street, Parkville, Victoria, Australia; University of Melbourne Centre for Cancer Research, The Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
  • Cancel-Tassin G; CeRePP, Hopital Tenon, Paris, France; Sorbonne Universite, GRC n°5 Predictive Onco-Urology, APHP, Tenon Hospital, Paris, France.
  • Cussenot O; CeRePP, Hopital Tenon, Paris, France; Sorbonne Universite, GRC n°5 Predictive Onco-Urology, APHP, Tenon Hospital, Paris, France.
  • Loda M; Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Sander C; cBio Center, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hayes VM; Garvan Institute of Medical Research, The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia; School of Medical Sciences, University of Sydney, Charles Perkins Centre, Camperdown, NSW, Australia.
  • Dalsgaard Sorensen K; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University Hospital, Aarhus N, Denmark.
  • Lu YJ; Centre for Biomarker and Therapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Hamdy FC; Nuffield Department of Surgical Sciences University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK.
  • Foster CS; The Institute of Cancer Research, London, UK.
  • Gnanapragasam V; Department of Surgery, Division of Urology, University of Cambridge, Cambridge, UK.
  • Butler A; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, UK.
  • Lynch AG; School of Medicine, University of St Andrews, St Andrews, Fife, UK; School of Mathematics & Statistics, St Andrews, Fife, UK.
  • Massie CE; CRUK Cambridge Institute, Hutchison MRC Research Centre, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Woodcock DJ; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK.
  • Cooper CS; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Wedge DC; Manchester Cancer Research Centre, The University of Manchester, Manchester, UK.
  • Brewer DS; Norwich Medical School, University of East Anglia, Norwich, UK; The Earlham Institute, Norwich Research Park, Norwich, UK.
  • Kote-Jarai Z; The Institute of Cancer Research, London, UK. Electronic address: Zsofia.Kote-Jarai@icr.ac.uk.
  • Eeles RA; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.
Eur Urol ; 82(2): 201-211, 2022 08.
Article en En | MEDLINE | ID: mdl-35659150
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Fosfatidilinositol 3-Quinasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Fosfatidilinositol 3-Quinasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza